Tofacitinib in acute severe ulcerative colitis: review addressing seven key unmet needs
Tofacitinib, an oral Janus kinase (JAK) inhibitor, shows promise as a rescue therapy for acute severe ulcerative colitis (ASUC), a life-threatening condition marked by high colectomy rates. This narrative review synthesizes evidence from randomized controlled trials (RCTs), observational studies, an...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2025-09-01
|
| シリーズ: | Therapeutic Advances in Gastroenterology |
| オンライン･アクセス: | https://doi.org/10.1177/17562848251374638 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|